Journal of the Royal Society of Medicine

Pricing for new drugs lacks transparency

The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal of ...

Dec 08, 2014
popularity not rated yet | comments 0